Search for a command to run...
No change among Promoters and Institutions indicates a lack of confidence from smart money in Vaishali Pharma Ltd.
Public shareholding decreased by 1.14% YoY, contrasting with stable sector averages, suggesting waning retail interest.
Best-performing peer SANOFICONR saw a significant 20.63% increase in institutional stake, highlighting Vaishali Pharma's underperformance in a growing sector.
| Category | Trend | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter5 | 26.62% | 26.62% | 26.32% | 26.32% | 26.32% | 26.32% | 26.32% | 26.32% | |
2Institution1 | - | - | - | - | 1.39% | - | - | - | |
3Public15 | 28.83% | 20% | 21.32% | 23.67% | 17.74% | 19.05% | 20.18% | 16.6% |